Mission: We at BDR Pharmaceuticals are here to become a strategic innovator & enhance healthcare by
30/07/2021
Your body can better incorporate the effects of medication while on treatment if you choose to keep off from a few habits. The aim of by BDR Pharma is to help you understand and avoid the practices that can be a roadblock in your recovery.
30/07/2021
BDR Pharma, in sight of the 3rd wave of COVID-19, gears up! We have inked a licensing deal with the Defence Research and Development Organisation (DRDO) to manufacture and sell a COVID drug, 2-Deoxy-D-Glucose, in the country. Follow this link to know more about the drug and hear the thoughts of Mr Dharmesh Shah, Chairman of BDR Pharma, on the development.
BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country.
27/07/2021
Prescribed medication can impact your health more effectively if you make a few positive lifestyle changes. Here's to help you identify habits to adopt while on medication so you can respond to it with more efficacy.
26/07/2021
It's not unusual to miss taking your medicines. Despite the best of efforts, eventually, everyone misses one or more doses. The remedy for this situation is to ask your doctor in advance. Since the recommendations differ for each drug, it can prevent the therapy from failing.
22/07/2021
The key to surviving and defeating cancer is timely detection and getting the right treatment. We teamed up with ETHealthworld to discuss the advancements of cancer treatment with Rucaparib. Watch the webinar to delve into details on how advancements in the field are yielding a better tomorrow for cancer patients.
21/07/2021
An active ingredient is the ingredient of the medicine that allows it to treat one’s body. By identifying these ingredients we can prevent allergic reactions, overdose as well as harmful interactions with other medicines. to help you stay safe and healthy.
19/07/2021
Before reaching for a pill over the counter, it’s crucial to consider the effects it would have on your health. Knowing how the drug would work provides the rationale for its use in the treatment and learning about the side effects helps take precautionary measures. We hope the helps you with making the right decisions when beginning any kind of medication.
16/07/2021
Bringing to you a snippet of the insightful live session with The Times of India where Dr Shona Nag discusses ovarian cancer - its early signs, detection and much more. To watch the complete video, visit: https://bit.ly/3hLH9rL
16/07/2021
All medicines have one generic name and perhaps one or more brand names. That's why, to avoid overlap of drugs and steer clear of counterfeit medication, we require detailed information on the medication well in advance. Hope that this step in can help you sail through your treatment with ease.
14/07/2021
Knowing what medication we take, why we take them, the dosage and the possible side effects are very important. That’s why we plan to dedicate this month to the must-knows of medication because we understand keeping medication and prescriptions aligned can be tricky. So, stay tuned for !
08/07/2021
In this session, organized by ETHealthworld.com and BDR Pharma, leading health experts will come together to discuss the advancements of cancer treatment with Rucaparib. Ovarian and prostate cancer, when treated early, can significantly improve survival rates. Hence, join the session by registering through the link below and learn more about effective treatment options against these cancers. https://health.economictimes.indiatimes.com/webcast/rucaparib-ray-of-light-against-breast-ovarian-and-prostate-cancers/935
Address
BDR Pharmaceuticals Internationals Pvt. Ltd. “Engineering Center” 6th Floor, 9th Mathew Road, Opera House Mumbai 400004
Be the first to know and let us send you an email when BDR Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Established in 2002 into API manufacturing, we have a consolidated position in the domestic and global market for the API Business.
In today’s dynamic global pharmaceutical market, we at BDR Pharmaceuticals have carved a niche for ourselves, with our formulations portfolio for specialty medication. Our unique strategy of multi-branding ensures that critical and lifesaving medicines are available at affordable prices with two API and formulation facilities at Gujarat, Uttarakhand and a pellet facility at Hyderabad.
Awards/Accolades/Achievements-
Enjoys Star Export House status, recognized and issued by Ministry of Commerce & Industry.
Recipient of Outstanding Exports Award from Pharmexcil.
DSIR accreditation for BDR Pharma R&D facility and API R&D at Baroda.
BDR is the first generic formulator in the world for many lifesaving molecules.
Mr Dharmesh Shah has been bestowed with “The Hurun India Award 2019 for Industry Achievement in the field of Pharmaceuticals”
Company Milestones -
Established in 2002 as a Merchant Exporter.
Internationally recognized and renowned Merchant Exporter of API and finished products since 2002.
Star Export House status, recognized and issued by Ministry of Commerce & Industry.
API manufacturing facility called Virdev Intermediates in 2006 in Surat, Gujarat
BDR Lifesciences another API manufacturing facility at Vadodara, Gujarat in 2010.
Pellets manufacturing facility located in Hyderabad, Telangana in 2013.
BDR Pharmaceuticals International Pvt Ltd has a dedicated oncology oral manufacturing facility in Vadodara, Gujarat in 2015
DSIR accreditation for BDR Pharma R&D facility and API R&D at Baroda.
First generic formulation manufacturer in life saving critical segments.
Critical segments are:
Oncology
Neurology
Gynaecology
Fifth Generation antibiotics
Achieved 30 % growth since inception in 2003.
In the process of filing Dossiers in a number of international markets for product registration with tech transfer understanding.
· In today’s perspective, BDR is one of the fastest growing companies in India, focusing in two critically vital areas of operations, i.e. 1. Expanding products basket in each therapeutic segment and 2. From a futuristic view, building a world-class and state-of-the-art modern infrastructure qualifying for USA and European accreditations.
· We boast of having already built an in operation, contemporary R & D, F &D spread over an expansive area of 65000 sq ft and capable of undertaking research works in diverse fields. We have an ambitious programme to qualify this modern, state-of-the-art R&D - F&D Centre through USFDA inspection soon and then proceed for filing ANDA from this site.
· BDR is strengthening /diversifying our manufacturing capabilities through building two large production blocks , i.e. 1. for General Lyophilisation, Liquid Injection and Dry Powder and 2. dedicated Oncology unit for Soft Gel, Dry Powder Depot and PFS . Probably, BDR will qualify for the distinction of being the 1st Company in India for having manufacturing areas for Oncology lyophilisation as well as liquid injection under the same roof.
Reputed Indian pharmaceutical companies who are our marketing partners in formulation business :
